Skip to main content
LFMD
NASDAQ Life Sciences

LifeMD Slashes Full-Year Outlook as Q3 Revenue Misses Guidance

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.54
Mkt Cap
$79.772M
52W Low
$1.6
52W High
$5.375
52W Position info
3.7% below low
Off High info
71% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

LFMD is trading near its 52-week low of $1.6 (3.7% below the low).

Summary

LifeMD posted Q3 revenue of $44.6 million, down 7% year-over-year and below its own guidance, and cut full-year 2026 revenue guidance to $188-191 million from $205.5-212.5 million. The EBITDA outlook deteriorated far more: full-year adjusted EBITDA is now guided to a loss of $12.6-10.6 million versus the prior negative $6.0 million to breakeven, and Q4 is guided to a loss of $2-4 million, with Q4 revenue seen at $46 million to $49 million. The quarter's loss per share was 11 cents. Management blamed a deliberate $9.5 million sequential cut in marketing spend and partnerships ramping slower than expected, though it points to cost per acquisition down 32% and adjusted EBITDA improving about $3.1 million sequentially to roughly breakeven. This lands days after the company disclosed it was delaying its Q3 10-Q to correct revenue and expense recognition errors, so the reported numbers carry added scrutiny. Cash stood at $21.9 million with no debt at quarter end, and they closed a $12.5 million senior secured term loan with Avenue Capital afterward to fund working capital for branded GLP-1 fulfillment. The stock is already near its 52-week low, and a guidance reset of this size keeps pressure on the equity.

At the time of this announcement, LFMD was trading at $1.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $79.8M. The 52-week trading range was $1.60 to $5.38. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

LFMD - Latest Insights

LFMD
Nov 12, 2026, 4:58 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.61
Real-time Price: $1.91 info
Change: +$0.300 (+19%) info
Market Cap: $79.772M info
LFMD
Nov 12, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.49
Real-time Price: $1.91 info
Change: +$0.420 (+28%) info
Market Cap: $79.772M info
LFMD
Nov 09, 2026, 9:39 AM EST
Source: Reuters
Importance Score:
9
Price at Filing: $1.98
Real-time Price: $1.91 info
Change: -$0.070 (-4%) info
Market Cap: $79.772M info
LFMD
Sep 15, 2026, 10:18 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.30
Real-time Price: $1.91 info
Change: -$1.39 (-42%) info
Market Cap: $79.772M info
LFMD
Aug 05, 2026, 4:56 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $3.40
Real-time Price: $1.91 info
Change: -$1.49 (-44%) info
Market Cap: $79.772M info